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Introduction
In Europe, the end of the 1990s saw the development of a 
multidisciplinary approach for cancer patients undergoing 
surgery, particularly in the case of colorectal cancer. The 
objective was to reduce the surgical stress on the patient 
and at the same time reduce the cost of hospitalization (1). 
Different strategies have been proposed under various 
names, including fast-track surgery, enhanced recovery 
program, accelerated rehabilitation care, and enforced 
multimodal rehabilitation care.
Given the growing interest in this field, especially in the 
West, a specific study group was organized in the context of 
the European Society of Clinical Nutrition and Metabolism 
(ESPEN) in 2001. The term enhanced recovery after 
surgery (ERAS) came into usage for the first time in 2002. 
Later, in 2009, emerging data from preliminary studies 
guided the issuance of the first consensus guidelines (2). 
Soon, principles first adopted in colorectal surgery became 
more commonly applied in other procedures. However, 
specific ERAS guidelines for gastric cancer were not 
published until 2014 (ERAS-GC) (3). Consequently, the 
literature has little to offer regarding institutions that have 
adopted an ERAS-GC protocol. In addition, while evidence 
has been growing in recent years, results are difficult to 
generalize due to differences in patient characteristics, 
disease extension, and health systems.
Table 1 summarizes the randomized studies published 
from the issuing of the ERAS Society guidelines (4-9).
The ERAS-GC guidelines consist of two sections. The 
first includes general enhanced recovery items that coincide 
with the guidelines for pancreaticoduodenectomy (10), while 
the procedure-specific guidelines contain eight elements (3): 
preoperative nutrition, preoperative oral pharmaconutrition, 
access, wound catheters and transversus abdominis 
plane block, nasogastric/nasojejunal decompression, 
perianastomotic drains, early postoperative diet and artificial 
nutrition, and audit. This review offers an analysis of the 
principles and future perspectives of the ERAS-GC program.
Preoperative nutrition
A recent study, exploring the effects of preoperative nutrition 
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in patients with gastric cancer, showed a direct correlation 
for both short-term (risk of infection) and long-term 
survival and disease recovery (11). This finding highlights 
that adequate nutrition, commencing immediately at 
the start of the perioperative period, has a considerable 
impact that cannot be overlooked. In comparison, 
the guidelines suggest the need to identify patients 
suffering malnutrition and to determine its severity (3). 
That said, routine preoperative parenteral nutrition is not 
recommended in the absence of specific needs.
More recently, randomized trials (12-14) have introduced 
the concept of immune nutrition, aiming to modulate the 
systemic inflammatory response. In particular, researchers 
have found that omega-3 fatty acid and arginine reduce the 
duration of systemic inflammatory response syndrome and 
the incidence of infectious postoperative complications (12). 
Mochiki (13) also described the effect of glutamine on the 
recovery of intestinal motility. Three reviews and meta-
analyses (15-17) related to immunonutrition confirmed that 
perioperative nutritional support is effective for improving 
patient immunity and modulating the inflammatory 
response; however, evidence is lacking concerning the 
modalities, timing, and characteristics of patients that can 
receive the most benefit as well as product formulations.
Minimally invasive surgery
The ERAS guidelines (3) recommend the use of minimal-
access surgery in order to facilitate short incisions, resulting 
in less trauma to the tissues. However, in gastric surgery, 
albeit the use of laparoscopy and robotic surgery is 
spreading in referral centers, significant debate continues 
regarding the use of these approaches for advanced gastric 
cancer (AGC). As another factor in the discussion, AGC 
represents the majority of patients undergoing surgery in 
Western countries. Although some authors have published 
the results of ERAS-GC with open access, minimally 
invasive surgery represents a fundamental element for 
the success of an ERAS-based program as it provides 
support for guaranteeing reduced stress to tissue and rapid 
physiological recovery.
Authors of systematic reviews and meta-analyses have 
attempted to define the role of minimally invasive surgery 
(laparoscopy, robotic surgery, hybrid procedures) for gastric 
cancer by comparing it with the open approach (18-20). 
The guidelines describe laparoscopy as a possible alternative 
to open surgery for early gastric cancer (21); meanwhile, 
robotic surgery possesses intrinsic technological advantages 
as articulated instruments may be comfortably controlled 
from a remote console while offering a 3D view.
Several issues are currently subject to debate in 
gastric cancer (22,23). Most important is ensuring 
proper oncological surgery by performing an adequate 
lymphadenectomy. In randomized trials (19), laparoscopy 
demonstrated the removal of an adequate number of lymph 
nodes as required by international guidelines (21).
As another factor, robotic surgery can facilitate better 
D2 dissection. Advanced technology clearly offers intrinsic 
advantages for this surgical step, but researchers have not 
yet proven and verified these through appropriate trials: 
only four studies (24-27) have contrasted robotic surgery 
with the open approach, and only one study showed 
a statistically significant difference in comparison to 
laparoscopy (28).
Among the intraoperative outcomes, most of the 
available studies found that minimally invasive surgery led 
to reduced blood loss. This finding achieved high statistical 
significance for laparoscopy in Vinuela’s meta-analysis of 
Table 1 Characteristics of current Randomized controlled trials, published since the introduction of the ERAS guidelines for gastrectomy
Author Year Language Approach ERAS group (No.) Control group (No.) Type of surgery Main outcomes reported
Wang (4) 2014 Chinese Open 71 71 NR LHS, RBF, HC
Abdikarim (5) 2015 English Laparoscopy 30 31 DG, TG LHS, C, RBF
Bu (6) 2015 English Open 128 128 DG, TG LHS, C, R, RBF, HC
Liu (7) 2016 English Open/laparoscopy 42 42 DG, TG LHS, C, RBF, HC
Mingjie (8) 2016 English Open 73 76 NR LHS, C, RBF
Kang (9) 2018 English Laparoscopy 46 51 DG LHS, C, M, R, RBF
LHS, length of hospital stay; C, complications; M, mortality; R, readmission; RBF, return of bowel function; HC, hospital cost; DG, distal 
gastrectomy; TG, total gastrectomy; NR, not reported; ERAS, enhanced recovery after surgery. 
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RCTs (19). Meanwhile, with regard to robotic surgery, a 
general consensus among different studies has described 
some advantages over laparoscopy and open surgery in 
reducing operative bleeding (28,29). Several studies, 
however, have also reported conflicting results (30,31).
Regarding the post-operative period, the largest 
RCT (32), performed by the Korean Laparoscopic 
Gastrointestinal Surgery Study Group, found no significant 
difference between laparoscopy and open surgery 
concerning overall complications. In contrast, other 
studies have shown a significant reduction in medical and 
minor surgical complications when using laparoscopy (19). 
Moreover, researchers’ findings have been inconsistent 
in studies examining robotic surgery when attempting to 
demonstrate differences compared to laparoscopy in terms 
of analyzing complications (24,30,33).
Overall, despite the extreme heterogeneity among 
studies, minimally invasive surgery has demonstrated 
relevant advantages when compared with open surgery 
in the area of postoperative hospital stays (20). Some 
evidence has indicated that patients who underwent robotic 
gastrectomy could be discharged at an earlier date than 
patients who underwent open or laparoscopic gastrectomy 
(34,35). However, the low number of studies in this field 
along with high heterogeneity weaken this conclusion.
Manually handling organs during surgery is an important 
contributor to the inflammatory response after surgery (36). 
Thus, the smaller minimally invasive instruments may 
cause less inflammation than the instruments used in open 
surgery.
Nasogastric/nasojejunal decompression
Studies (37,38) concur that the nasogastric/nasojejunal 
tube should not be used routinely in subjects eligible for 
the ERAS-GC protocol. The literature has reported no 
advantage from its routine use (5). In fact, those studies 
(37,38) have shown that use of the nasogastric tube does 
not reduce the risk of anastomotic leakage, the number of 
pulmonary complications, or mortality; in addition, such use 
significantly reduces the patient’s post-operative comfort. 
Furthermore, in Yang’s meta-analysis (39), the authors 
showed that postoperative tube maintenance prolongs 
postoperative ileus and time to the first flatus. Yamada (40) 
also reported that complications potentially caused by a 
shortening of the postoperative fasting period, such as ab-
ingestis pneumonia or anastomotic leakage, do not increase 
under the ERAS protocol.
Perianastomotic drains
The guidelines recommend avoiding the use of abdominal 
drainage to reduce related complications and accelerate 
patient recovery (3); however, the level of evidence is low, 
and only a few cases have been analyzed in a recent meta-
analysis of the Cochrane Library (41).
In any event, the absence of abdominal drainage is an 
additional factor that improves patient comfort as well 
as stimulates and facilitates walking. While the scientific 
evidence does not show any benefit in the use of abdominal 
drainage for numerous surgical procedures (42,43), in 
the case of gastric surgery, little evidence is available. In 
particular, the use of drainage after total gastrectomy is 
still widely debated in the context of the ERAS programs. 
Therefore, caution is necessary in this case, particularly 
after extensive lymphadenectomy.
Mobilization
A fundamental item in the ERAS protocol (3) is early 
mobilization, which is facilitated by the absence of the 
nasogastric tube and drainage as well as by early removal 
of the urinary catheter. Smart (44) showed that failure to 
mobilize patients early is significantly associated with a 
lengthening of post-operative hospitalization. Many studies 
(35,40,45,46) have shown that the application of this item of 
the ERAS program can significantly accelerate the recovery 
of post-operative intestinal function in comparison to a 
group subjected to conventional management.
Early postoperative diet
The ERAS protocols require that the patient should not 
be subjected to long periods of fasting. It has been amply 
demonstrated that early nutrition reduces postoperative 
catabolism, accelerates the return of intestinal function, 
and reduces the risk of complications (47,48). Furthermore, 
Lewis et al. (49) confirmed in their meta-analysis that 
keeping patients fasted does not yield any benefit. In fact, 
although the topic remains controversial, several studies 
(46,50) have shown that early oral nutrition is not only 
feasible in gastric surgery but brings significant benefits. 
Despite the fact that an early dietary recovery has been 
shown to speed up the patient’s recovery after several 
surgical procedures, concerns (actually unfounded) related 
to possible correlation with higher risk of anastomotic 
leakage or bowel obstruction have caused this approach 
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following gastrectomy to be viewed with distrust. Recent 
studies (40,51) have confirmed that early feeding after 
gastrectomy is safe and associated with an improvement in 
functional recovery and a reduction in hospital stay.
In particular, a randomized controlled trial (52) reported 
safety data on oral feeding resumption from the second post-
operative day after gastrectomy. Studies by Makuuchi (53) 
and Pedziwiatr (54), comparing the adoption of an 
ERAS protocol versus conventional management after 
gastrectomy, confirmed the observation that the recovery 
of oral nutrition is safe from the second postoperative day. 
This practice was also found to correlate with a reduction 
in post-operative administration of intravenous fluids and 
early discharge (55).
In comparison, Sugisawa (56) focused on evaluating the 
rate of anastomotic leakage and ab-ingestis pneumonia to 
assess the real risk attributable to early nutrition. In this 
study (56), the incidence of anastomotic leakage was 0.8% 
in the ERAS group, a value not only lower than that of its 
historical comparison cohort (1.7%) but also in line with or 
lower than the data rendered by previous studies reporting 
conventional perioperative management (0.8–1.9%). 
Therefore, the author concluded that early oral nutrition 
does not negatively affect the anastomotic site. Yamada 
(40,57) obtained results that revealed a similar incidence in 
the rate of leakage (1.1%).
On this topic, the guidelines (3) do not clearly state 
the different steps to take in resuming oral intake after 
gastrectomy, but they support an early administration of 
oral liquids from the first postoperative day. For those 
patients who are unable to reach at least 60% of the 
required caloric intake, a tailored nutritional support is 
recommended. This item, however, is much debated: some 
authors (58) underline the difficulty in developing specific 
protocols due to considerable differences regarding type of 
gastrectomy, stage of disease, and the general condition of 
the patient.
Perspectives
The effects of adopting an ERAS-GC program depend 
not only on clinical factors but also on health systems 
and the socio-cultural substrate of patients. For example, 
Yamada (40) reported that although ERAS patients 
had a more rapid functional recovery than those in the 
conventional group, the length of hospital stay did not 
differ significantly between the two groups. The authors 
attributed this result primarily to the Japanese Diagnosis 
Procedure Combination-based Payment System (DPC) 
that allows patients to extend their stay at a reduced cost. 
Among others, Sugisawa (56) reported that the median 
postoperative hospital stay was significantly reduced in 
the ERAS group (8 days) compared to its historical cohort 
(10 days; P=0.001). Wang (46) obtained similar results.
Regarding post-operative complications and the need for 
reoperations, all studies (35,40,53,56) confirmed the safety 
of the ERAS approach. Furthermore, they identified no 
statistically significant difference between the experimental 
and control groups.
Since the publication of the ERAS-GC guidelines, four 
meta-analyses (59-62) have been published. Li (61) showed 
that ERAS-GC with the laparoscopic approach allows a 
reduction in postoperative hospitalization and reduced 
costs due to faster recovery without an increase in the 
readmission rate or complications. In their study, Ding 
et al. (59) revealed that ERAS improves the postoperative 
inflammatory response. In addition, Wang (62) reported 
that ERAS quickens the recovery process with significant 
reduction in surgical stress and hospitalization costs in 
addition to improving the nutritional aspects and the quality 
of life of the patients.
While such evidence is prompting referral centers to 
adopt strategies, in the spirit of ERAS, to optimize the 
management of patients with gastric cancer, it is admittedly 
difficult to generalize the results. In the end, each 
institution, depending on its needs, should create its own 
patient-based pathways.
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